Seniors with higher glutathione levels had fewer illnesses, lower cholesterol, lower body mass index, and lower blood pressure
Between late 2023 and 2024, the FDA moved several popular peptides to the Category 2 list, citing concerns about insufficient human safety data and the potential for immunogenicity (the property of provoking an immune response)
What would I consider a successful outcome, and is that expectation realistic for this product category
Some patients reported developing a flat affect
Rising diabetes and obesity prevalence, strong clinical outcomes, patient awareness, insurance coverage, and demand for effective, convenient metabolic therapies drive growth
Glutathione, a master antioxidant naturally present in the body, works by neutralizing free radicals, reducing oxidative stress, and promoting detoxification at the cellular level